Morphological changes in bladder tissue after submucosal injection of mitomycin C solution in experiment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the results of morphological examination of bladder tissue reactions on the submucosal injection of mitomycin-C solution in different (0.1, 0.05, 0.025, and 0.0125%) concentrations. The experiments were conducted using dogs weighing 13-15 kg. Tissue sampling for histological evaluation were performed at 1, 2 and 3 hours, and on Day 7, 14, and 30. Maximum expression of the inflammatory response in the submucosa (edema, foci of lymphohistiocytic infiltration, increased microvascular lumen, diffuse leukocyte infiltration around the vessels of connective tissue between muscle fibers) was developed early after injection of 0.1% mitomycin-C, and it was minimal 3 hours after injection of 0.0125 % solution.

Full Text

Restricted Access

About the authors

A. G Kostyuk

Vinnitsa National Medical University n.a. N.I. Pirogov

Email: opersurgery@vnmu.edu.ua
Department of Oncology, Radiodiagnosis and Radiation Therapy

References

  1. Лопаткин Н.А., Мартов А.Г., Гущин Б.Л. Диагностика и лечение рецидивов поверхностного рака мочевого пузыря (ранняя повторная цистоскопия и биопсия). Урология. 2003; 5: 45-49
  2. Серегин И.В., Фигурин К.М., Самойленко В.М., Кисилевский М.В. Современные подходы к лечению рака мочевого пузыря Клинич. медицина. 2004; 3: 50-54.
  3. Babjuk M., Oosterlinck W., Sylvester R. et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update. Eur. Urol. 2011; 6: 997-1008.
  4. Pankaj P. Dangle, Wang W.P., Mayerson J. et al. Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma ten years after radical cust ectomy. World J. Surg. Oncol. 2008; 6: 103.
  5. Sylvester R.J., Oosterlinck W., van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta Tl bladder cancer: a metaanalysis of published results of randomized clinical trials. J. Urol. 2004; 6: 2186-2190.
  6. Oddens J.R., van der Meijden A.P., Sylvester R.J. One immediate postoperative instillation of chemotherapy in low risk Ta, Tl bladder cancer patients. Is it always safe? Eur. Urol. 2004; 3: 336-338.
  7. Sylvester R.J., Oosterlinck W., Witjes J.A. The schedule and duration of intravesical chemotherapy in patients with non muscle invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur. Urol. 2008; 4: 709-719.
  8. Malmström P.U. Bladder Tumours: time for a paradigm shift? Br. J. Urol. Int. 2011; 10: 1543-1545.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies